Home / Resources / Audit reports

Audit reports · 4 min read

What a QP Expects from an API Supplier Audit Report

In pharmaceutical manufacturing, the quality of Active Pharmaceutical Ingredients (APIs) directly affects the quality, safety, and consistency of the finished medicine. For this reason, evaluating API suppliers is an important part of pharmaceutical quality management.

A supplier audit report provides documented evidence of a supplier's quality systems, manufacturing practices, and compliance with applicable Good Manufacturing Practice (GMP) requirements. For a Qualified Person (QP), this report can be an important source of information when assessing supplier compliance and supporting decisions related to pharmaceutical product quality.

However, simply having an audit report is not enough. The report must be relevant, sufficiently detailed, evidence-based, and appropriate for its intended purpose.

1. Clear Audit Scope and Objectives

A QP needs to understand exactly what the audit covered and whether it is relevant to the API being supplied.

A good audit report should identify:

  • The supplier's name and manufacturing site
  • The API or activities covered by the audit
  • The audit date and duration
  • The applicable GMP standards and audit criteria
  • The processes, departments, and systems assessed
  • Any exclusions or limitations in the audit scope

For example, an audit covering only warehousing may not provide sufficient evidence about API manufacturing operations if the intended assessment is to qualify the manufacturing site.

2. Auditor Competence and Independence

The credibility of an audit report depends partly on the competence and impartiality of the auditor.

The report should provide sufficient information about the audit organization, the auditor's relevant experience, and the approach used to conduct the assessment. Any actual or potential conflict of interest should be appropriately managed.

An independent, technically sound audit can provide greater confidence in the reliability of its findings.

3. Findings Supported by Objective Evidence

Audit findings should clearly explain what was observed and why it matters.

A strong report includes:

  • A clear description of each finding
  • Relevant records, observations, or other supporting evidence
  • The applicable requirement or audit criterion
  • The potential impact on product quality, patient safety, or compliance
  • The classification or risk level of the finding, where applicable

For example, identifying that laboratory audit trails were not adequately reviewed is more useful when the report also explains the evidence examined and the potential implications for data integrity.

Findings should be specific, traceable, and sufficiently detailed to support an informed quality decision.

4. CAPA Status and Corrective Actions

Identifying deficiencies is only one part of the audit process. The report should also explain how significant findings are being addressed.

A QP or Quality Unit may need to understand:

  • Whether corrective and preventive action (CAPA) plans have been established
  • Whether root causes have been investigated
  • Whether corrective actions have been implemented
  • Whether supporting evidence has been reviewed
  • Whether action effectiveness has been assessed, where applicable
  • Whether significant findings remain open

An audit report with unresolved critical issues may require further evaluation before it can support a supplier-qualification decision.

5. Supplier Risk and GMP Compliance

The report should provide a clear picture of the supplier's overall compliance status and any risks that could affect the API.

Relevant areas may include:

  • Pharmaceutical Quality System
  • Manufacturing and process controls
  • Laboratory controls and analytical testing
  • Data integrity
  • Deviations, change control, and CAPA
  • Material traceability and supply-chain controls
  • Documentation and record management
  • Relevant regulatory inspection history

The significance of each finding should be considered in relation to the supplier's activities, the API involved, and the potential impact on product quality.

6. Is the Audit Report Suitable for Its Intended Purpose?

A QP or Quality Unit should not assume that every existing audit report is automatically acceptable.

The report should be assessed for its relevance, scope, completeness, and currency. The reviewer should consider whether the audit covered the correct site and activities, whether significant findings are adequately addressed, and whether the available evidence supports the intended supplier-qualification or monitoring decision.

Where important gaps remain, additional documentation, follow-up, or a supplementary audit may be necessary.

7. The Role of the Quality Unit and Qualified Person

The supplier audit report is one component of the broader pharmaceutical quality system. It should be considered alongside other relevant information, including supplier qualification records, material specifications, quality agreements, supplier performance, and applicable regulatory requirements.

The Quality Unit and QP have distinct responsibilities within the pharmaceutical quality framework. Their specific involvement depends on the applicable regulations, the product, and the organization's quality procedures.

An audit report can support their evaluation, but it does not automatically establish supplier approval or replace other required quality assessments.

Conclusion

A useful API supplier audit report should provide more than a list of observations. It should present a clear audit scope, credible evidence, appropriately documented findings, CAPA status, and an understandable assessment of supplier risks.

For pharmaceutical organizations, reviewing these elements helps determine whether an audit report is suitable for its intended purpose and whether further assessment is needed.

At PharmaTrak, our focus is on independent, evidence-based GxP audits and fit-for-purpose audit report reviews that help organizations evaluate supplier compliance, identify gaps, and make informed quality decisions.

Regulatory note: This article is intended for general educational purposes. The acceptance of an audit report depends on applicable regulatory requirements, the intended purpose, and the organization's quality system. It does not replace a QP's responsibilities or the need for a case-specific quality assessment.

Discuss your audit requirements

Independent, evidence-based GxP audits from PharmaTrak.

Request an Audit